Source: Journal of thoracic oncology. Conference titles: World conference on lun cancer - ASLC. Unidade: FM
Subjects: ADENOCARCINOMA, DERRAME PLEURAL, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Lisete et al. Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 01 nov. 2024. , 2017APA
Teixeira, L., Acencio, M., Alvarenga, V., Silva, G., Brito, Z., Fernezlian, S., et al. (2017). Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/SNLM
Teixeira L, Acencio M, Alvarenga V, Silva G, Brito Z, Fernezlian S, Puka J, Martins J, Capelozzi V. Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S1276-S1277.[citado 2024 nov. 01 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/SVancouver
Teixeira L, Acencio M, Alvarenga V, Silva G, Brito Z, Fernezlian S, Puka J, Martins J, Capelozzi V. Anti-VEGF and Anti-EGFR Reduce Malignant Pleural Effusion and Morbidity in an Experimental Adenocarcinoma Model [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S1276-S1277.[citado 2024 nov. 01 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
